Case closed Sep 20, 2024
Clovis Oncology is in a post-effective-date liquidation posture: the docket reflects notice of the effective date of its Third Amended Joint Chapter 11 Plan of Liquidation and related claims bar dates in the supplemental effective-date notice mailingDkt. 1040. The operative path is therefore asset monetization and claims administration under a liquidation plan, rather than a going-concern reorganization.
Updated Sep 5, 5:05 AM ET
Final Claims Register (Alpha). Filed by Kroll Restructuring Administration LLC. (Attachments: # 1 (Numeric) Final Claims Register)
Dkt. 1194 · Nov 14, 2024
Quarterly Claims Register (Alpha). Filed by Kroll Restructuring Administration LLC. (Attachments: # 1 (Numeric) Quarterly Claims Register)
Dkt. 1193 · Nov 12, 2024
Chapter 11 Post-Confirmation Report for Case Number 22-11293 for the Quarter Ending: 10/23/2024 (Clovis Oncology UK Limited). Filed by Alexandre Zyngier as Liquidation Trustee of the Clovis Liquidation Trust.
Dkt. 1191 · Nov 4, 2024
Use with MCP to query this case from your own tools.
Record as of September 6, 2026. Docket entries and dates come from the court. Nothing on this page is AI-generated.